GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medeze Group PCL (BKK:MEDEZE) » Definitions » Net Issuance of Preferred Stock

Medeze Group PCL (BKK:MEDEZE) Net Issuance of Preferred Stock : ฿0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Medeze Group PCL Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Medeze Group PCL's net issuance of preferred for the six months ended in Dec. 2024 was ฿0.0 Mil. The number is 0, which means that Medeze Group PCL has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Medeze Group PCL's net issuance of preferred for the trailing twelve months (TTM) ended in Dec. 2024 was ฿0.0 Mil.


Medeze Group PCL Net Issuance of Preferred Stock Historical Data

The historical data trend for Medeze Group PCL's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medeze Group PCL Net Issuance of Preferred Stock Chart

Medeze Group PCL Annual Data
Trend Dec23 Dec24
Net Issuance of Preferred Stock
- -

Medeze Group PCL Semi-Annual Data
Dec23 Dec24
Net Issuance of Preferred Stock - -

Medeze Group PCL Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Dec. 2024 was ฿0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medeze Group PCL Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Medeze Group PCL's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Medeze Group PCL Business Description

Traded in Other Exchanges
N/A
Address
Phuttha Monthon Sai 4 Road, 28/9 Moo 8, Krathum Lom, Sam Phran, Nakhon Pathom, THA, 73220
Medeze Group PCL is engaged in the business of providing stem cell storage, analyzing, isolation, cultivation and preservation services for medical use. It is organised into four reportable segments: Stem cell sample collection service segment; White blood cell potential testing service segment; Other services segment and Sales of products segment.

Medeze Group PCL Headlines

No Headlines